Upcoming Events

University of Oxford Module on Adverse Drug Reactions, Drug Interactions and Pharmacovigilance in the MSc Course in Experimental and Translational Therapeutics

Our director gave a lecture on Pharmacovigilance inspections and audit strategy on the University of Oxford MSc on 15th May. She enjoyed teaching a group of individuals from around the world with differing backgrounds

PIPA PSMF face to face training course

Our director is leading the PIPA PSMF face to face training course that will be held on 10th June at the Springer Healthcare office in London. The training course includes a pre-training webinar on GVP Module II.

RQA Virtual Conference 2025

Our director will be speaking at the RQA Virtual Conference on 21st May about the Windsor Framework and PV. The RQA Virtual Conference runs from 20th to 22nd May.

European Forum for Good Clinical Practice (EFGCP) Covid-19 webinars

Our director was one of the organisers of the European Forum for Good Clinical Practice (EFGCP) Covid-19 webinars.

3rd European Pharmacovigilance Congress in Milan

Our director was a presenter at the 3rd European Pharmacovigilance Congress in Milan in 2019 and has been invited back to take part in a round table in 2020.

European Forum for Good Clinical Practice (EFGCP) Covid-19

Our director presents in European Forum for Good Clinical Practice (EFGCP) Covid-19 webinars:

• 27 Jul 2020: Clinical Trials in COVID19: Challenges and Opportunities in Medical
• 08 Jun 2020: Clinical Trials During the Coronavirus Pandemic: Safety Matters20.

PIPA Advanced Pharmacovigilance Skills: Current Hot Topics PIPA training update

Our director is looking forward to running the PIPA Advanced Skills training course again this year on 21Apr2020

Due to the COVID-19 pandemic the course will be run as an interactive online webinar. 

This interactive course will cover the following subjects:

• PV isn’t always black and white
• PV interaction with Quality
• Signals to Safety Variations
• Pharmacovigilance System Master File and its challenges
• Third party agreements
• Risk management
• Key Performance Indicators